Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07103057 · ClinicalTrials.gov registry record

VIZ ACCESS HCM - Multi-Site Registry

A clinical trial of Hypertrophic Cardiomyopathy, sponsored by Viz.ai.

Recruiting
Registry status
500
Enrollment target
3
Study locations

NCT07103057 is a study of Hypertrophic Cardiomyopathy that is actively recruiting participants, run by Viz.ai. The registered enrollment target is 500 participants, below the 1,301-participant average among 10 other Hypertrophic Cardiomyopathy trials with a reported enrollment target (62% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07103057, a study of Hypertrophic Cardiomyopathy, is actively recruiting participants, sponsored by Viz.ai.

RECRUITING
Registry status
500 participants
Enrollment target
3
Study locations

Study Summary

To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best integrate AI screening tools and their potential impact.

Conditions Studied

Hypertrophic Cardiomyopathy

Interventions

  • DEVICE Viz HCM

Study Locations (3)

Georgia

  • Emory University - Atlanta

Illinois

  • North Shore University Health System - Evanston

Pennsylvania

  • Thomas Jefferson University - Philadelphia

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-06-13
Est. Completion 2028-12

Sponsor

Viz.ai

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07103057

The ClinicalTrials.gov registry entry for NCT07103057 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,301-participant average among 10 other Hypertrophic Cardiomyopathy trials with a reported enrollment target (62% lower). The listed sponsor is Viz.ai, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertrophic Cardiomyopathy appearing as the primary indexed condition, and to 1 intervention - of which Viz HCM is the first listed.

NCT07103057 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Georgia, Illinois, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07103057 about?

NCT07103057 is a clinical study titled "VIZ ACCESS HCM - Multi-Site Registry". To describe the clinical, economic, and population characteristics of newly diagnosed, previously diagnosed, and suspected patients evaluated by Viz HCM. HCM is underdiagnosed in the community and AI algorithms have been developed as screening tools. However, it is not well understood how to best in...

What is the current status of trial NCT07103057?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-06-13. Estimated completion is 2028-12.

What conditions does trial NCT07103057 study?

This clinical trial studies the following conditions: Hypertrophic Cardiomyopathy.

What interventions are being tested in trial NCT07103057?

The interventions under investigation include: Viz HCM (DEVICE).

Who is sponsoring clinical trial NCT07103057?

This trial is sponsored by Viz.ai, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07103057 being conducted?

This trial has 3 study locations across Georgia, Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertrophic Cardiomyopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertrophic Cardiomyopathy

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.